Masaki Muramatsu

526 total citations
61 papers, 357 citations indexed

About

Masaki Muramatsu is a scholar working on Transplantation, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masaki Muramatsu has authored 61 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Transplantation, 24 papers in Surgery and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masaki Muramatsu's work include Renal Transplantation Outcomes and Treatments (32 papers), Renal and Vascular Pathologies (17 papers) and Renal Diseases and Glomerulopathies (12 papers). Masaki Muramatsu is often cited by papers focused on Renal Transplantation Outcomes and Treatments (32 papers), Renal and Vascular Pathologies (17 papers) and Renal Diseases and Glomerulopathies (12 papers). Masaki Muramatsu collaborates with scholars based in Japan, United Kingdom and Australia. Masaki Muramatsu's co-authors include Seiichiro Shishido, Atsushi Aikawa, Ken Sakai, Takeshi Kawamura, Yuko Hamasaki, Shinya Hayashi, S. Takahashi, Akira Hasegawa, Hideyo Oguchi and Kenji Ishikura and has published in prestigious journals such as Transplantation, Pediatric Nephrology and ˜The œNephron journals/Nephron journals.

In The Last Decade

Masaki Muramatsu

53 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaki Muramatsu Japan 11 195 134 104 99 92 61 357
Koji Nanmoku Japan 12 183 0.9× 135 1.0× 115 1.1× 84 0.8× 58 0.6× 40 402
Isabel Roberti United States 10 153 0.8× 116 0.9× 98 0.9× 56 0.6× 61 0.7× 22 306
P.G.P Machado Brazil 12 231 1.2× 133 1.0× 70 0.7× 63 0.6× 50 0.5× 29 343
Kohei Unagami Japan 11 185 0.9× 108 0.8× 93 0.9× 72 0.7× 50 0.5× 57 294
Elisabeth Dittrich Austria 9 157 0.8× 109 0.8× 130 1.3× 35 0.4× 44 0.5× 12 385
Kenta Futamura Japan 11 121 0.6× 98 0.7× 92 0.9× 56 0.6× 69 0.8× 54 296
Kazuhiro Iwadoh Japan 10 201 1.0× 174 1.3× 86 0.8× 169 1.7× 111 1.2× 28 377
Emre Arpalı Türkiye 10 136 0.7× 159 1.2× 34 0.3× 69 0.7× 66 0.7× 34 320
Ana Cristina Carvalho de Matos Brazil 11 89 0.5× 77 0.6× 58 0.6× 49 0.5× 46 0.5× 29 239
Diana Carretero Spain 7 111 0.6× 123 0.9× 287 2.8× 53 0.5× 70 0.8× 8 428

Countries citing papers authored by Masaki Muramatsu

Since Specialization
Citations

This map shows the geographic impact of Masaki Muramatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Muramatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Muramatsu more than expected).

Fields of papers citing papers by Masaki Muramatsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Muramatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Muramatsu. The network helps show where Masaki Muramatsu may publish in the future.

Co-authorship network of co-authors of Masaki Muramatsu

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Muramatsu. A scholar is included among the top collaborators of Masaki Muramatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Muramatsu. Masaki Muramatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Muramatsu, Masaki, et al.. (2023). Urinary excretion of thyroid hormone in CKD patients: a proof-of-concept of nephrogenic hypothyroidism. Renal Failure. 45(2). 2293224–2293224. 5 indexed citations
3.
Okuda, Makoto, Hiromu Suzuki, Masaki Muramatsu, et al.. (2023). PASSENGER LYMPHOCYTE SYNDROME IN LIVING DONOR KIDNEY TRANSPLANTATION AFTER RITUXIMAB TREATMENT. Japanese Journal of Transfusion and Cell Therapy. 69(1). 15–19.
4.
Oguchi, Hideyo, Naobumi Tochigi, Tetuo Mikami, et al.. (2023). Significance of Multinucleated Polyploidization of Tubular Epithelial Cells in Kidney Allografts. ˜The œNephron journals/Nephron journals. 147(Suppl. 1). 28–34. 1 indexed citations
5.
Oguchi, Hideyo, Tetuo Mikami, Masaki Muramatsu, et al.. (2023). Vesicoureteral Reflux Causes Interstitial Inflammation in Pediatric Kidney Allograft: A Clinicopathological Analysis of 1-Year Protocol Biopsies. ˜The œNephron journals/Nephron journals. 147(Suppl. 1). 89–95.
6.
Shinoda, Kazunobu, Hideyo Oguchi, Tetuo Mikami, et al.. (2022). Outcome of ABO‐incompatible kidney transplantation using a modified desensitization protocol without plasmapheresis. International Journal of Urology. 29(9). 1017–1025. 3 indexed citations
7.
Hamasaki, Yuko, et al.. (2022). Changes in graft function after living donor kidney transplantation in children. Pediatric Nephrology. 38(1). 291–297.
8.
Satoh, Hiroyuki, Atsuko Sato, Yosuke Morizawa, et al.. (2021). Long-term outcomes of living-donor kidney transplant children weighing less than 15 kg: Comparison of the surgical approach. Journal of Pediatric Urology. 17(4). 542.e1–542.e8. 5 indexed citations
9.
Hamasaki, Yuko, Riku Hamada, Masaki Muramatsu, et al.. (2020). A cross-sectional nationwide survey of congenital and infantile nephrotic syndrome in Japan. BMC Nephrology. 21(1). 363–363. 1 indexed citations
10.
Aikawa, Atsushi, Masaki Muramatsu, Kazunobu Shinoda, et al.. (2019). Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies. PubMed. 17(Suppl 1). 43–49. 2 indexed citations
11.
Oguchi, Hideyo, Tetuo Mikami, Yutaka Yamaguchi, et al.. (2019). Can Lipofuscin Deposition on Renal Allograft Tubular Epithelium Be a Surrogate Marker for Kidney Allograft Aging?. Transplantation Proceedings. 51(5). 1343–1347. 2 indexed citations
12.
Aikawa, Atsushi, et al.. (2018). Surgical Challenge in Pediatric Kidney Transplant Vascular Anastomosis.. Experimental and Clinical Transplantation. 16(Suppl 1). 14–19. 2 indexed citations
13.
Hamasaki, Yuko, Masaki Muramatsu, Riku Hamada, et al.. (2017). Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan. Clinical and Experimental Nephrology. 22(3). 719–726. 8 indexed citations
14.
Yamazaki, Ken’ichi, Ken Sakai, Yasushi Ohashi, et al.. (2017). Similar Anemic Control Between Chronic Kidney Diseases in Patients With and Without Transplantation on Entry to Dialysis. Transplantation Proceedings. 49(1). 57–60. 2 indexed citations
15.
Shishido, Seiichiro, et al.. (2012). Outcomes of Pediatric ABO-Incompatible Kidney Transplantations Are Equivalent to ABO-Compatible Controls. Transplantation Proceedings. 44(1). 214–216. 27 indexed citations
16.
Takagi, Koji, Masaki Muramatsu, Hideo Kunisada, & Yasuo Yuki. (2005). Synthesis of Triazine-Based Solid Polymer Electrolyte Bearing Oligo (ethylene oxide) Chain. KOBUNSHI RONBUNSHU. 62(5). 208–213. 1 indexed citations
17.
Sugiyama, Ken, K Arai, Atsushi Aikawa, et al.. (2005). Reversibility From Delayed Hyperacute Rejection in ABO-Incompatible Renal Transplantation: Histopathological Findings of Renal Allograft Biopsy. Transplantation Proceedings. 37(2). 701–704. 3 indexed citations
18.
Sakai, Ken, Masaki Muramatsu, K Arai, et al.. (2004). BK virus nephropathy in a patient with ABO‐incompatible renal transplantation. Clinical Transplantation. 18(s11). 39–43. 2 indexed citations
19.
Aikawa, Atsushi, Takahiro Ohara, K Arai, et al.. (2001). Donor specific antibody suppression in ABO incompatible kidney transplantation. Transplantation Proceedings. 33(1-2). 395–397. 6 indexed citations
20.
Mizuno, Takumi, Kazuki Nakashima, Kenichiro Shibata, et al.. (1981). [A case report of subdiaphragmaticomediastinal lipoma of dumbbell type through the foramen of Morgagni (author's transl)].. PubMed. 34(6). 478–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koji Nanmoku Breakdown of academic impact, for papers by Isabel Roberti Breakdown of academic impact, for papers by P.G.P Machado Breakdown of academic impact, for papers by Kohei Unagami Breakdown of academic impact, for papers by Elisabeth Dittrich Breakdown of academic impact, for papers by Kenta Futamura Breakdown of academic impact, for papers by Kazuhiro Iwadoh Breakdown of academic impact, for papers by Emre Arpalı Breakdown of academic impact, for papers by Ana Cristina Carvalho de Matos Breakdown of academic impact, for papers by Diana Carretero
Rankless by CCL
2026